How do I transition oncology patients from intravenous immunoglobulin to subcutaneous immunoglobulin in an outpatient clinic?
{{output}}
Background: Intravenous immunoglobulin (IVIG) treating secondary immunodeficiency (SID) for oncology patients causes strain for outpatient clinic capacity. Home-based subcutaneous immunoglobulin (SCIG) offers equivalent efficacy ... ...
